Wednesday, May 1, 2019
ivWatch Announces Expansion into Canada with Distributor Roxon

ivWatch, a leading provider of biosensor technology focused on improving patient safety and the effectiveness of intravenous (IV) therapy, has entered into an exclusive distribution agreement with Roxon medi-tech

The agreement includes the rights to distribute the ivWatch Model 400, the only device to receive clearance, globally, to offer early detection of infiltrations/extravasations, in the Canadian market.

Click here to read the complete Press Release.